≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Use of galantamine

Endpoint Browser

ADMED_ACHEI_GALANTAMINE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — N06DA04

1 out of 7 registries used, show all original rules.

2597

4. Check minimum number of events

Min. number of events 3
2597

5. Include endpoints

None

2597

6. Filter based on genotype QC (FinnGen only)

2597

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2597 1216 1381
Unadjusted period prevalence (%) 0.52 0.41 0.61
Median age at first event (years) 79.57 79.47 79.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2066
Matched controls
20661
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DX01
ATC
memantine; oral
12.5
323.0
1088
1693
G30.1
ICD-10 Finland
Alzheimer disease with late onset
11.7
323.0
997
1529
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
13.3
323.0
952
1245
N06DA04
ATC
galantamine; oral
+∞
323.0
2066
74
P20
ICPC
Memory disturbance
7.1
323.0
1084
2771
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
8.7
225.9
537
797
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
12.1
183.1
352
344
SPAT1053
SPAT
Memory test
3.9
163.4
921
3534
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
7.3
161.1
426
712
G30.8
ICD-10 Finland
Other Alzheimer disease
9.4
157.5
347
433
N05AX08
ATC
risperidone; systemic
5.2
156.5
560
1370
N06DA03
ATC
rivastigmine; oral, transdermal
5.7
130.7
419
883
P70
ICPC
Dementia
7.3
104.7
269
416
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
11.0
80.5
159
156
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.5
79.6
432
1455
N06DA02
ATC
donepezil; oral
3.5
78.2
428
1448
N05AH04
ATC
quetiapine; oral
3.4
75.3
431
1505
G30
ICD-10 Finland
Alzheimer disease
8.6
71.4
161
200
G30.0
ICD-10 Finland
Alzheimer disease with early onset
11.8
69.6
132
119
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
6.7
67.4
180
289
SPAT1216
SPAT
Assessment of functional ability
2.6
66.8
638
3066
F03
ICD-10 Finland
Unspecified dementia
3.3
58.6
338
1168
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.5
56.3
293
935
F06.7
ICD-10 Finland
Mild cognitive disorder
4.8
54.9
193
430
A28
ICPC
Limited function/disability NOS
2.3
54.0
681
3691
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
51.5
579
2955
F0019, G301
ICD-10 Finland
NA
8.1
49.9
116
151
SPAT1301
SPAT
No procedures
2.0
45.3
831
5190
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.7
44.9
350
1455
SPAT1234
SPAT
Support of social functional capacity
3.1
44.1
266
938
SPAT1254
SPAT
Administration of medicine
2.2
42.1
514
2684
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
11.7
42.1
79
70
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
37.7
387
1849
N06AB10
ATC
escitalopram; oral
2.5
37.5
335
1490
L28
ICPC
Limited function/disability (L)
2.0
36.1
551
3140
N06AX11
ATC
mirtazapine; oral
1.9
35.6
680
4215
N05BA04
ATC
oxazepam; oral
1.9
30.9
584
3566
N02BE01
ATC
paracetamol; systemic, rectal
1.9
30.9
1712
14720
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
6.9
29.9
76
114
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
28.3
822
5731
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
5.2
27.9
89
178
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
27.4
350
1826
N06AX26
ATC
vortioxetine; oral
4.2
26.2
103
256
SPAT1101
SPAT
Orthostatic test
2.5
24.4
201
849
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
24.1
480
2942
SPAT1229
SPAT
Assessment of need for aid
2.1
23.6
285
1445
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
22.6
296
1552
AA1AD
NOMESCO Finland
CT of head and brain
1.7
22.3
635
4330
R53
ICD-10 Finland
Malaise and fatigue
1.7
22.2
548
3580
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
13.4
21.5
37
28
R41.3
ICD-10 Finland
Other amnesia
3.1
21.4
123
416
SPAT1252
SPAT
Overall medication plan or its review
2.2
21.4
237
1155
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
20.9
606
4137
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
5.7
20.1
58
104
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
19.7
442
2789
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
19.2
153
631
A04
ICPC
Weakness/tiredness general
1.8
18.6
349
2081
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
18.5
654
4670
A29
ICPC
General symptom/complaint other
1.9
18.5
288
1609
TAB00
NOMESCO Finland
Lumbar puncture
3.8
17.4
74
199
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
17.4
655
4733
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.6
16.9
76
215
WYA20
NOMESCO Finland
Home visit
3.2
16.6
87
277
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
16.4
524
3624
130
Kela drug reimbursment
Malignant tumour
0.3
16.3
39
1197
F0009, G300
ICD-10 Finland
NA
7.7
15.4
35
46
S06.0
ICD-10 Finland
Concussion
1.9
15.3
229
1258
SPAT1263
SPAT
Sampling
1.5
15.2
808
6260
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
15.1
252
1438
SPAT1360
SPAT
Extensive global examination
2.0
15.1
199
1041
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
14.7
170
841
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.9
14.5
241
1373
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
14.4
693
5244
SPAT1251
SPAT
Organisation of medication
2.3
14.3
140
644
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
14.0
271
1620
N06AB04
ATC
citalopram; systemic
1.6
14.0
395
2635
C10AA01
ATC
simvastatin; oral
1.4
13.8
1129
9457
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
13.6
349
2269
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
13.3
226
1297
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
11.5
13.3
24
21
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
13.1
140
670
N03AG01
ATC
valproic acid; systemic, rectal
2.5
13.0
106
444
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.6
12.9
92
360
U04
ICPC
Incontinence urine
2.1
12.7
150
751
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
12.5
226
1319
SPAT1139
SPAT
Nutrition survey
2.5
12.0
93
379
F009, G309
ICD-10 Finland
NA
4.1
11.9
45
111
SPAT1172
SPAT
Guidance concerning hydration
2.3
11.3
103
459
SPAT1260
SPAT
Consultation of another employee
1.6
11.3
345
2337
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
7.1
11.0
26
37
H02AB02
ATC
dexamethasone; systemic
0.4
10.9
37
973
I95.1
ICD-10 Finland
Orthostatic hypotension
2.0
10.9
138
710
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
10.9
699
5519
A06AD11
ATC
lactulose; oral
1.5
10.7
468
3431
SPAT1262
SPAT
Handing over of treatment supplies
1.5
10.7
371
2589
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
10.6
116
560
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.5
10.4
78
315
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
10.4
130
664
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
10.4
152
826
SPAT1167
SPAT
Insertion of urinary catheter
2.1
10.2
114
559
Z75.5
ICD-10 Finland
Holiday relief care
3.0
10.0
57
193
N29
ICPC
Neurological sympt/complt other
3.3
9.8
48
149
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.3
760
6211
F05.1
ICD-10 Finland
Delirium superimposed on dementia
3.6
9.1
39
109
N28
ICPC
Limited function/disability (N)
3.0
8.8
48
161
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.4
8.8
76
330
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
8.7
154
895
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
7.7
8.6
19
25
N05AH03
ATC
olanzapine; systemic
2.4
8.6
69
290
A98
ICPC
Health maint/preventive medicine
1.4
8.5
1498
13655
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.5
8.4
64
262
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
8.3
179
2675
JN4BD
NOMESCO Finland
Extensive body CT
0.5
8.1
83
1486
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
8.0
108
572
G04CA02
ATC
tamsulosin; oral
1.3
8.0
608
4888
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
3.8
7.9
32
86
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.9
510
3990
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.9
7.8
108
578
N02AA05
ATC
oxycodone; systemic
1.4
7.7
378
2814
F0014, G301
ICD-10 Finland
NA
6.4
7.7
19
30
WX402
NOMESCO Finland
General anaesthesia
0.5
7.7
57
1122
AA1AD
SPAT
NA
10.1
7.5
14
14
C10AA05
ATC
atorvastatin; oral
1.3
7.5
787
6619
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
7.4
355
2630
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.0
7.4
*
185
XA800
NOMESCO Finland
Neuropsychological investigation
2.8
7.3
45
165
W19
ICD-10 Finland
Unspecified fall
1.6
7.3
204
1348
J01DB01
ATC
cefalexin; oral
1.3
7.3
1364
12368
N05AD01
ATC
haloperidol; systemic
2.0
7.3
88
450
A99
ICPC
Disease/condition unspecnature/site
1.7
7.2
155
957
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
7.2
148
901
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
15.8
7.2
11
7
K08.3
ICD-10 Finland
Retained dental root
1.8
7.2
120
684
E0000UV
ATC
NA
1.3
7.2
622
5080
Z04.3
ICD-10 Finland
Examination and observation following other accident
3.0
7.2
38
127
SPAT1014
SPAT
Treatment of eyes
2.5
7.1
53
214
E86
ICD-10 Finland
Volume depletion
2.0
7.1
80
398
N30.0
ICD-10 Finland
Acute cystitis
1.4
7.0
305
2221
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
7.0
7.0
16
23
R55
ICD-10 Finland
Syncope and collapse
1.5
6.9
278
1990
N06AB06
ATC
sertraline; oral
1.8
6.8
117
675
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
0.4
6.8
20
557
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.8
723
6065
SPAT1050
SPAT
Extensive neurological examination
2.3
6.7
58
257
F0029, G308
ICD-10 Finland
NA
4.7
6.7
21
45
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
22.6
6.7
9
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.6
175
1143
F01.2
ICD-10 Finland
Subcortical vascular dementia
3.7
6.6
26
70
A04AA02
ATC
granisetron; systemic, transdermal
0.3
6.5
13
434
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
6.2
6.5
16
26
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.4
6.5
30
695
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
6.4
341
2571
F01.8
ICD-10 Finland
Other vascular dementia
14.3
6.4
10
7
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
6.4
120
716
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.2
6.4
60
277
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.2
6.3
60
278
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
9.3
6.3
12
13
S01.0
ICD-10 Finland
Open wound of scalp
1.6
6.2
162
1051
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
4.3
6.2
21
49
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
6.2
450
3574
Z29
ICPC
Social problem NOS
2.5
6.1
44
178
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.7
6.1
230
3110
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
6.0
*
251
S72.0
ICD-10 Finland
Fracture of neck of femur
1.6
6.0
149
956
N27
ICPC
Fear of neurological disease other
2.7
6.0
37
138

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
1074
5880
2.41
98.69
1.9
1.9
nmol/l
1238.2
1176.2
1.39
828
4310
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
87
113
7.93
63.08
1.1
1.0
ng/l
402.1
311.3
1.67
59
61
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
87
114
7.86
62.61
1.1
1.0
ng/l
56.3
42.8
1.48
59
62
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
87
114
7.86
62.61
1.1
1.0
ng/l
561.2
599.8
0.32
58
60
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1347
9815
1.77
43.77
2.3
2.2
pmol/l
93.0
92.1
0.29
726
4976
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
803
5293
1.75
34.98
1.9
1.8
pmol/l
482.7
7211970.1
1.28
624
4160
(3019150) Specific gravity of Urine by Refractometry
681
4378
1.75
31.89
5.5
5.2
kg/l
1.0
1.0
2.18
80
751
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
724
4750
1.73
31.46
2.5
3.1
mmol/l
2.4
2.5
5.26
627
4079
(3021960) Folate [Moles/volume] in Serum or Plasma
854
6028
1.62
27.26
1.6
1.7
nmol/l
21.7
19.7
1.59
727
5085
(3015377) Calcium [Moles/volume] in Serum or Plasma
1033
7638
1.59
27.09
2.3
3.1
mmol/l
2.4
2.3
1.30
868
6354
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1070
8020
1.57
26.20
2.0
2.2
nmol/l
78.9
80.8
1.45
894
6787
(3031040) Bacteria [#/volume] in Urine by Automated count
1682
13993
1.57
25.56
6.1
5.9
e6/l
3876.1
3190.5
0.20
60
295
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1298
10201
1.54
25.44
4.2
5.6
mmol/l
1.2
1.2
8.05
1147
9029
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1191
9231
1.54
24.56
4.4
4.7
ng/l
71.7
71.2
0.01
971
7426
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
102
334
3.14
24.54
1.2
1.3
mg/l
485.4
572.5
1.03
93
317
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1841
15823
1.56
22.56
4.8
4.9
mu/l
2.1
2.1
0.26
1615
13837
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
912
6773
1.53
22.29
2.3
2.1
u/l
242.2
231.7
0.12
851
6258
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
90
293
3.15
21.88
1.3
1.3
e6/l
4.2
40.4
1.16
74
242
(3029937) Albumin [Presence] in Urine by Test strip
741
5277
1.57
21.78
5.4
5.1
estimate
0.0
0.0
0.00
134
1607
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
90
294
3.14
21.76
1.3
1.4
e6/l
496.9
966.2
0.46
76
250
(40761535) Cells panel - Urine sediment
329
1942
1.79
19.79
4.0
4.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
78
249
3.20
19.62
1.2
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1375
11340
1.45
18.85
4.3
6.3
mmol/l
1.2
1.2
4.97
1119
9394
(3022217) INR in Platelet poor plasma by Coagulation assay
580
4031
1.57
18.52
25.8
33.2
inr
1.5
1.6
0.51
89
509
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1988
17680
1.53
18.12
17.5
19.9
mg/l
29.5
28.9
0.31
1692
14999
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
419
2725
1.64
17.58
10.3
9.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2050
18477
1.52
16.33
21.9
24.3
mmol/l
139.8
139.4
8.69
1969
17853
(3023103) Potassium [Moles/volume] in Serum or Plasma
2050
18492
1.52
16.11
21.9
24.5
mmol/l
4.0
4.0
0.48
1964
17835
(3024731) MCV [Entitic volume]
2057
18583
1.51
15.91
25.7
29.0
fl
92.2
92.0
0.78
1990
18061
(3035941) MCH [Entitic mass]
2057
18583
1.51
15.91
25.6
28.9
pg
30.5
30.4
2.25
1989
18061
(3007461) Platelets [#/volume] in Blood
2057
18583
1.51
15.91
25.7
29.0
e9/l
231.3
236.0
2.66
1974
17855
(3026361) Erythrocytes [#/volume] in Blood
2057
18584
1.51
15.89
25.8
29.1
e12/l
4.3
4.3
0.22
1962
17768
(3000963) Hemoglobin [Mass/volume] in Blood
2057
18586
1.51
15.87
25.9
29.3
g/l
129.3
128.4
1.85
1988
18082
(3010813) Leukocytes [#/volume] in Blood
2057
18592
1.51
15.78
25.8
29.1
e9/l
7.3
7.1
0.63
1962
17766
(3019225) pH of Specimen
359
2331
1.63
15.01
3.9
4.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
918
7248
1.41
14.83
2.4
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
42
108
3.94
14.68
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1948
17520
1.45
14.38
17.4
19.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1507
12990
1.38
14.08
3.7
3.9
pmol/l
15.2
15.3
0.45
1302
11272
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
908
7244
1.39
13.47
5.2
5.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1178
9818
1.37
13.27
3.2
4.3
g/l
34.8
33.8
8.57
1047
8907
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
599
4470
1.44
12.92
1.8
1.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1985
18052
1.42
12.63
20.4
23.6
umol/l
85.7
88.1
2.90
1980
18045
(3011397) Hemoglobin [Presence] in Urine by Test strip
617
4677
1.42
12.10
5.2
4.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
262
3986
0.62
12.08
1.5
1.6
mmol/l
1.1
1.3
7.17
210
3244
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
364
2504
1.53
11.71
2.5
2.5
ug/l
4.3
5.9
2.46
276
2032
(3009261) Glucose [Presence] in Urine by Test strip
1138
9589
1.33
11.28
4.9
4.7
estimate
0.0
0.0
0.00
151
1715
(3035350) Ketones [Presence] in Urine by Test strip
1125
9466
1.33
11.25
4.8
4.6
estimate
0.0
0.0
0.00
153
1745
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
188
1110
1.75
11.19
2.1
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
249
1590
1.63
11.04
1.5
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
209
2.72
10.81
2.7
3.2
umol/l
311.7
333.4
0.60
45
174
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
173
1009
1.77
10.75
1.9
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1408
12316
1.31
10.34
3.8
4.7
mmol/l
7.1
7.0
1.14
1335
11581
(3021601) Nitrite [Presence] in Urine by Test strip
1114
9461
1.31
10.05
5.7
6.2
estimate
0.0
0.0
0.00
158
1709
(3014271) Vancomycin [Susceptibility]
54
213
2.57
9.39
2.9
3.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1948
17985
1.33
8.89
9.0
11.1
u/l
22.2
22.6
0.26
1807
16979
(3016018) Differential panel - Cerebral spinal fluid
36
121
3.00
8.46
1.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
812
6744
1.30
8.21
2.7
3.7
ph
7.4
7.4
1.42
133
1254
(3045414) Leukocytes [Presence] in Urine
136
802
1.73
8.18
2.4
2.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
44
169
2.63
8.11
2.7
3.4
mg/l
39.3
38.4
0.01
32
138
(4034850)
105
581
1.84
7.83
18.6
13.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1522
13718
1.26
7.70
5.2
5.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
197
1315
1.54
7.24
2.9
2.9
e6/l
0.7
0.3
0.85
192
1291
(3023368) Bacteria identified in Blood by Culture
864
7324
1.27
7.23
3.5
4.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1479
13352
1.25
7.09
24.1
27.0
g/l
330.3
329.6
2.42
1441
13105
(3015736) pH of Urine
887
7569
1.26
6.96
4.7
4.3
—
5.9
—
0
5
(3043409) Potassium [Moles/volume] in Arterial blood
128
793
1.65
6.47
3.0
3.3
mmol/l
3.9
3.9
0.05
117
719
(3026008) Bacteria identified in Urine by Culture
958
8323
1.24
6.24
3.9
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1701
15714
1.24
6.13
17.0
19.5
ml/min/173m2
66.6
65.4
1.71
1374
13040
(4024509)
49
227
2.18
6.07
1.6
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1496
13652
1.23
5.98
3.5
4.2
mm/h
15.1
16.6
2.95
1305
12249
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1615
14906
1.22
5.57
4.8
7.1
u/l
79.6
83.7
1.82
1446
13739
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
1226
0.56
5.54
4.5
7.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1726
16057
1.22
5.42
6.9
6.9
mmol/mol
42.6
41.9
2.06
1498
14229
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1778
16632
1.22
5.10
5.0
5.2
mmol/l
6.2
6.2
0.22
1497
14364
(3021589) Normoblasts [#/volume] in Blood
661
7673
0.81
4.87
8.9
10.7
e9/l
0.0
0.0
2.39
546
6171
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
129
860
1.53
4.85
1.8
2.0
ug/l
494.2
902.4
0.73
120
807
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
43
208
2.09
4.85
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
209
1533
1.40
4.79
3.0
3.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
34
707
0.47
4.68
2.8
3.6
mmol/l
1.9
1.7
0.48
34
696
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
212
2822
0.73
4.63
2.4
3.4
u/l
245.5
252.4
0.30
194
2599
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
802
7033
1.20
4.41
4.8
5.7
ug/l
2.9
5.2
2.86
691
6116
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
274
0.29
4.38
1.8
3.5
—
1011.7
—
0
34
(3028026) IgM [Mass/volume] in Serum or Plasma
51
908
0.55
4.34
1.5
1.8
g/l
1.8
1.5
0.12
43
786
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
381
3103
1.27
4.22
1.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
166
2260
0.72
4.18
1.2
1.3
iu/ml
38.8
40.2
0.05
52
709
(3038515) Glucose [Moles/volume] in Venous blood
34
674
0.50
4.11
2.8
3.7
mmol/l
9.8
7.9
1.44
34
662
(3002179) Metamyelocytes/100 leukocytes in Blood
93
1403
0.65
4.06
2.4
3.7
%
0.4
0.7
1.60
24
345
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
271
3419
0.77
4.06
2.0
2.5
%
20.7
20.5
0.09
218
2816
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
49
862
0.56
4.02
2.2
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
227
1739
1.33
3.99
1.7
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
754
8510
0.84
3.94
3.7
5.3
%
2.7
2.8
0.15
671
7768
(3022096) Basophils/100 leukocytes in Blood
734
8292
0.84
3.86
3.6
5.3
%
0.6
0.6
0.02
653
7578
(3019069) Monocytes/100 leukocytes in Blood
759
8547
0.84
3.84
4.0
5.6
%
9.0
9.0
0.11
677
7814
(3042936) Bacteria identified in Isolate by Culture
237
3018
0.76
3.81
1.8
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
378
3117
1.25
3.76
1.6
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
153
2071
0.72
3.73
1.2
1.2
u/ml
17.2
17.6
0.01
42
651
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
72
2.65
3.73
2.4
3.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
293
3616
0.79
3.67
1.9
2.4
g/l
2.2
2.2
0.02
254
3268
(3026493) Urate [Moles/volume] in Serum or Plasma
442
5210
0.82
3.64
2.3
2.9
umol/l
8589.7
8339.0
0.03
334
4269
(3020779) Urea [Moles/volume] in Serum or Plasma
159
2129
0.73
3.63
3.6
5.2
mmol/l
10.3
12.5
3.49
146
1970
(3018010) Neutrophils/100 leukocytes in Blood
758
8505
0.85
3.62
3.8
5.3
%
60.1
60.1
0.04
677
7771
(40768804) Tissue Pathology biopsy report
617
7035
0.84
3.55
2.1
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
112
1579
0.70
3.49
2.3
3.7
%
0.6
0.9
0.97
34
489
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
196
2528
0.76
3.47
2.6
3.6
ug/l
35.4
23.8
0.15
164
2126
(3025159) Blasts/100 leukocytes in Blood
95
1374
0.68
3.41
2.4
3.8
%
0.1
0.4
0.63
26
375
(3013512) EKG study
725
6425
1.18
3.40
4.2
4.9
—
—
—
0
0
(4281824)
5
192
0.26
3.38
1.0
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
779
8682
0.85
3.37
3.9
5.5
%
24.9
24.4
0.50
689
7873
(3028717) Thiamine [Mass/volume] in Blood
7
10
7.01
3.36
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
426
0.44
3.30
1.1
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
75
487
1.56
3.28
2.6
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1039
9492
1.16
3.27
2.6
3.1
u/l
50.7
57.4
1.34
907
8380
(3040151) Glucose [Moles/volume] in Capillary blood
56
339
1.67
3.26
14.2
7.6
mmol/l
9.5
7.4
1.40
38
280
(4035726)
114
1581
0.71
3.25
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
132
1786
0.73
3.24
1.9
2.4
u/l
34.0
36.6
0.43
105
1485
(3007164) IgA [Mass/volume] in Serum or Plasma
200
2542
0.77
3.18
1.2
1.5
g/l
2.8
2.9
0.21
94
1352
(3020891) Body temperature
139
1028
1.37
3.12
3.6
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
689
0.57
3.11
1.4
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
31
159
1.96
3.09
2.6
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
74
1100
0.66
3.08
1.2
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
53
846
0.62
3.06
3.8
5.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
88
1263
0.69
3.06
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
216
0.32
3.04
1.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
21
438
0.48
3.03
2.0
2.5
mmol/l
4.1
4.1
0.18
21
433
(3035285) Chloride [Moles/volume] in Venous blood
21
438
0.48
3.03
2.0
2.5
mmol/l
107.5
105.7
0.35
21
433
(3000492) Spirometry study
75
1108
0.67
3.03
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
126
922
1.39
3.03
1.3
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
434
0.48
2.96
2.0
2.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
60
923
0.64
2.95
1.7
2.9
mg/l
50.3
127.9
0.69
46
755
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
60
921
0.64
2.92
1.7
2.9
mg/l
55.7
64.8
0.13
46
759
(3019832) Treponema pallidum Ab [Presence] in Serum
51
312
1.65
2.89
1.0
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
328
3894
0.82
2.87
1.9
2.4
umol/l
11.3
11.3
0.06
286
3523
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
632
0.58
2.82
1.4
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
80
1149
0.69
2.81
2.3
2.7
g/l
11.6
10.8
0.43
69
1011
(3009445) Proteinase 3 Ab [Units/volume] in Serum
51
803
0.63
2.80
1.3
1.7
—
22.5
—
0
24
(3021440) Promyelocytes/100 leukocytes in Blood
110
1492
0.73
2.78
2.4
3.7
%
0.1
0.1
0.08
33
450
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
54
834
0.64
2.73
1.8
2.7
u/ml
105.2
6112.8
1.10
40
711
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
283
0.39
2.72
1.6
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1589
15068
1.14
2.71
4.0
4.1
mmol/l
1.2
1.2
1.39
1348
12909
(42870588) Differential panel, method unspecified - Blood
575
6456
0.86
2.63
3.5
5.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
1063
0.69
2.62
1.2
2.3
g/l
3.9
3.8
0.30
48
719
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
100
1360
0.72
2.59
1.4
1.6
g/l
1.7
1.5
0.94
78
1135
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1723
16453
1.14
2.57
4.9
5.3
mmol/l
2.4
2.4
0.78
1490
14384
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
1011
0.68
2.56
1.2
2.3
g/l
10.4
10.5
0.03
50
820
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
1067
0.69
2.53
1.2
2.3
g/l
7.5
7.6
0.12
49
744
(3033658) Prothrombin time (PT) actual/Normal
433
4955
0.85
2.52
3.0
3.9
%
79.2
80.3
0.38
424
4802
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
1065
0.70
2.51
1.2
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
272
0.40
2.51
3.4
3.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
63
0.00
2.42
0.0
2.0
—
33230.2
—
0
37
(3017704) Immunofixation for Urine
5
160
0.31
2.41
1.0
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
208
0.38
2.40
1.5
1.2
nmol/l
—
0.3
—
0
14
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
67
0.00
2.38
0.0
2.1
—
565.3
—
0
52
(3000850) Epithelial cells [#/volume] in Urine
563
5018
1.16
2.38
2.7
2.8
e6/l
5.4
5.2
0.23
484
4403
(3044889) 12 lead EKG panel
1352
12753
1.13
2.36
4.8
4.7
—
—
—
0
0
(4211845)
22
111
1.99
2.35
3.1
4.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
523
0.59
2.31
1.2
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
185
0.38
2.28
1.6
1.2
nmol/l
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
41
254
1.62
2.27
1.3
1.2
nmol/l
330.8
288.0
0.61
31
195
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
61
0.00
2.23
0.0
1.6
—
4.0
—
0
26
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
626
5646
1.14
2.23
4.5
5.0
%
21.8
22.5
0.54
348
3092
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
282
2388
1.20
2.21
4.4
4.8
%
35.8
34.4
1.15
184
1467
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
73
2.20
2.21
1.6
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1653
15817
1.12
2.18
4.5
4.6
mmol/l
4.2
4.3
1.07
1443
13883
(3011985) Renin [Units/volume] in Plasma
8
195
0.41
2.17
1.0
1.2
mu/l
149.6
62.8
—
8
161
(3011288) Drugs identified in Urine by Screen method
6
14
4.29
2.15
1.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
167
0.36
2.13
1.3
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
136
1717
0.78
2.12
1.2
1.3
titre
623.8
517.4
0.23
32
396
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
207
0.43
2.07
1.4
1.2
nmol/l
0.5
0.7
—
9
192
(3044007) Cell count panel - Peritoneal fluid
0
56
0.00
2.06
0.0
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
1066
0.73
2.01
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
187
0.43
1.93
1.5
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
51
0.00
1.88
0.0
2.0
—
4.2
—
0
46
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
87
1144
0.75
1.87
2.1
3.2
mmol/l
24.1
24.1
0.07
77
1018
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
36
228
1.59
1.87
1.7
1.5
u/ml
21.9
30.4
—
8
46
(3049717) Cytology report of Urine Cyto stain
129
1025
1.27
1.86
2.7
2.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
29
467
0.62
1.85
2.3
2.6
mg/l
1.6
1.9
1.71
24
393
(3003434) Protein [Mass/volume] in Pleural fluid
30
477
0.62
1.82
1.2
1.5
g/l
31.8
29.6
0.56
24
427
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
49
702
0.69
1.80
1.3
2.4
g/l
0.0
0.0
0.00
41
632
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
18
94
1.92
1.80
1.0
1.1
—
—
—
0
0
(4010399)
94
1212
0.77
1.77
1.5
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
90
687
1.32
1.77
1.9
3.3
mmol/l
24.8
25.0
0.18
69
594
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
154
0.39
1.75
1.0
1.1
—
59.9
—
0
8
(3017569) Oxygen content in Arterial blood
5
138
0.36
1.74
2.8
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
971
0.74
1.72
1.2
2.3
g/l
3.2
3.2
0.02
48
739
(3020630) Protein [Mass/volume] in Serum or Plasma
184
2192
0.83
1.72
1.4
2.4
g/l
67.0
65.5
1.86
154
1897
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
30
2.67
1.72
6.5
2.7
u/field
0.4
0.6
—
8
30
(21494814) CD8 cells/100 lymphocytes in Specimen
0
46
0.00
1.70
0.0
2.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
46
0.00
1.70
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
320
0.56
1.70
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
291
1.49
1.70
1.7
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
215
0.46
1.69
2.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1620
15590
1.10
1.68
4.4
4.6
mmol/l
1.4
1.4
0.10
1394
13537
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
149
1.68
1.66
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
110
871
1.27
1.66
1.5
1.5
%
1.7
1.7
0.05
90
686
(3018095) Leukocytes [#/volume] in Urine
833
7763
1.11
1.66
4.1
4.2
e6/l
127.0
157.1
0.36
641
5796
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
909
8512
1.10
1.64
3.0
3.4
ng/l
2046.1
2339.2
1.09
767
7423
(40760888) Immunoglobulin light chains.free panel - Serum
49
688
0.71
1.64
1.8
2.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
835
8929
0.90
1.63
3.5
4.9
e9/l
0.6
0.6
0.83
705
7449
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
438
0.64
1.61
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
350
0.60
1.58
1.9
2.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
272
0.55
1.54
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
71
1.98
1.54
2.9
1.9
umol/l
58.5
50.7
—
8
52
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
52
713
0.72
1.53
1.3
2.3
g/l
0.0
0.0
0.00
42
634
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
43
0.00
1.52
0.0
2.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
67
883
0.75
1.52
1.3
2.4
g/l
0.7
1.2
0.49
49
718
(3002582) Erythrocytes [#/volume] in Urine
747
6952
1.10
1.51
3.6
3.7
e6/l
59.5
109.4
1.53
607
5478
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
345
0.61
1.51
1.5
3.1
e9/l
4.2
4.7
0.67
21
345
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
21
2.86
1.50
1.3
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
33
489
0.67
1.49
1.2
2.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
45
0.00
1.49
0.0
1.3
—
28.8
—
0
37
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
37
2.44
1.48
1.4
1.5
ng/l
81.1
116.2
—
9
37
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
684
6345
1.11
1.48
2.2
2.4
u/l
63.2
58.4
0.33
623
5777
(3005322) IgE [Units/volume] in Serum or Plasma
45
627
0.71
1.47
1.1
1.2
u/ml
118.6
214.1
2.07
37
557
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
169
0.47
1.46
1.0
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
845
8984
0.91
1.43
3.5
4.9
e9/l
0.0
0.0
0.42
716
7526
(3023419) Bacteria identified in Sputum by Culture
17
290
0.58
1.42
1.6
2.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
827
0.76
1.41
1.3
2.2
g/l
37.3
36.5
0.60
46
666
(3045424) Erythrocytes [Presence] in Urine
37
255
1.46
1.38
1.8
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
184
1573
1.18
1.38
2.6
3.7
kpa
5.1
5.2
1.19
155
1410
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
13
67
1.95
1.38
2.9
2.9
umol/l
30.6
28.2
—
8
42
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
360
0.64
1.37
2.1
3.4
%
59.9
61.2
0.14
23
360
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
176
1503
1.18
1.34
2.7
3.1
ml/min/173m2
57.1
54.7
0.59
80
722
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
346
0.63
1.34
2.0
2.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
37
0.00
1.34
0.0
1.3
—
23.4
—
0
23
(3008536) Aspergillus sp Ab [Presence] in Serum
0
39
0.00
1.33
0.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
475
0.69
1.32
1.2
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
864
9148
0.92
1.31
3.7
5.1
e9/l
2.0
1.8
0.68
751
7784
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
46
625
0.73
1.31
1.8
1.6
titre
56.0
155.6
—
5
32
(3037756) Immunofixation for Serum or Plasma
46
625
0.73
1.31
1.1
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
295
0.61
1.31
1.2
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
270
0.59
1.31
1.2
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
995
0.79
1.30
1.8
2.4
u/ml
0.4
0.4
0.37
40
583
(46235355) HIV 1 and 2 tests - Meaningful Use set
99
1214
0.81
1.29
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
567
6117
0.91
1.29
2.9
3.1
mg/l
296.4
315.1
0.04
375
3886
(1761868) Lipid panel - Serum or Plasma
332
3686
0.89
1.28
3.2
3.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
110
903
1.23
1.28
3.5
3.3
nmol/l
0.8
0.8
0.46
84
681
(3004588) Protein electrophoresis panel - Serum or Plasma
159
1858
0.85
1.26
1.4
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
217
2473
0.87
1.25
2.1
3.3
mmol/l
2.2
2.0
0.30
172
1941
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
69
538
1.29
1.24
1.8
2.3
ug/min
112.0
80.6
0.26
33
301
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
58
754
0.76
1.24
1.3
2.3
g/l
0.0
0.1
1.96
47
670
(3012441) Differential panel - Pleural fluid
23
350
0.65
1.23
1.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
165
1917
0.85
1.22
1.3
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
267
2994
0.88
1.22
2.9
4.5
mmol/l
1.0
1.0
3.05
237
2671
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
264
0.60
1.21
1.3
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
295
3286
0.88
1.21
1.8
2.2
%
1.7
1.8
0.94
249
2804
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
431
0.69
1.20
1.5
1.5
iu/ml
0.1
20.3
—
10
122
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
145
0.48
1.19
1.1
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
145
0.48
1.19
1.1
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
200
0.55
1.19
1.0
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
219
2484
0.87
1.19
2.1
3.3
kpa
6.0
5.8
1.83
209
2388
(3009343) pH of Capillary blood
179
1551
1.17
1.17
2.6
3.7
ph
7.4
7.4
0.95
23
189
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
496
0.72
1.15
1.8
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
35
0.00
1.15
0.0
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
356
0.67
1.15
1.3
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
170
1958
0.86
1.14
1.5
1.9
g/l
0.2
0.2
0.36
156
1765
(3051611) Lipemic interference index of Serum or Plasma
16
259
0.62
1.14
3.9
3.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
103
1238
0.83
1.14
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
65
1.85
1.13
1.0
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
273
2446
1.13
1.12
1.8
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
30
2.34
1.12
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
107
891
1.21
1.11
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
257
0.62
1.11
1.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
22
329
0.67
1.10
1.3
1.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
7
136
0.51
1.09
1.0
1.1
—
65.6
—
0
5
(3006184) Hemoglobin [Mass/volume] in Capillary blood
46
604
0.76
1.08
1.7
2.3
g/l
130.2
124.6
0.80
39
445
(3028308) Erythrocytes [#/volume] in Pleural fluid
27
386
0.70
1.08
1.3
1.4
e6/l
133087.3
60851.9
0.48
15
234
(3023199) Leukocytes [#/volume] in Pleural fluid
30
419
0.71
1.06
1.2
1.4
e6/l
1360.2
1797.8
0.49
21
306
(3013115) Eosinophils [#/volume] in Blood
881
9250
0.93
1.05
3.6
5.1
e9/l
0.2
0.2
0.25
755
7846
(3008152) Bicarbonate [Moles/volume] in Arterial blood
190
1671
1.15
1.04
4.7
5.6
mmol/l
24.3
24.5
0.35
182
1559
(3023420) DNA double strand Ab [Units/volume] in Serum
6
125
0.48
1.04
1.0
1.3
—
34.3
—
0
6
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
29
406
0.71
1.04
1.2
1.2
—
116.4
—
0
11
(3006462) Nitrate [Presence] in Urine
17
106
1.61
1.02
2.9
4.8
—
—
—
0
0
(3035880) pH of Pleural fluid
11
190
0.58
1.02
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
227
0.61
1.02
1.3
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
219
2455
0.88
1.02
1.8
2.3
e9/l
63.2
67.0
1.01
176
1878
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
171
1496
1.15
1.02
2.6
3.6
mmol/l
2.0
2.2
0.27
113
1070
(3047181) Lactate [Moles/volume] in Blood
61
764
0.79
1.01
2.7
5.1
mmol/l
1.4
1.3
0.16
53
671
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
133
0.53
0.98
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
311
3408
0.90
0.98
1.8
2.5
mmol/l
0.8
0.8
0.05
269
3071
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
135
0.52
0.98
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
135
0.52
0.98
1.0
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
30
0.00
0.97
0.0
1.3
—
111.1
—
0
25
(3009015) Lactate [Moles/volume] in Synovial fluid
0
30
0.00
0.97
0.0
1.2
—
6.5
—
0
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
365
0.71
0.96
1.3
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1507
14642
1.07
0.96
17.7
22.1
%
37.5
36.4
2.52
769
8000
(40767503) Oxygen content in Capillary blood by calculation
43
557
0.77
0.95
1.9
2.5
%
17.2
15.5
1.60
21
283
(4027681)
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
116
0.52
0.94
1.0
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
234
2104
1.12
0.94
2.5
5.3
mmol/l
1.6
1.4
1.31
217
1988
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
119
0.50
0.93
1.0
1.1
—
5.6
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
145
0.55
0.93
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
184
0.60
0.92
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
632
0.79
0.92
1.1
1.1
iu/ml
28.9
114.5
4.57
17
210
(40768800) Prostate Pathology biopsy report
33
441
0.75
0.91
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
460
4928
0.92
0.91
2.0
2.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
106
1240
0.85
0.91
2.9
7.0
mmol/l
24.0
24.4
0.67
88
1116
(1616796) Gas panel - Central venous blood
44
564
0.78
0.90
2.5
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
106
1238
0.85
0.89
1.4
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
42
1.91
0.88
2.4
2.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
129
0.54
0.88
1.0
1.1
—
60.7
—
0
6
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
110
1278
0.85
0.88
2.7
6.1
mmol/l
25.0
24.9
0.15
110
1260
(3027315) Oxygen [Partial pressure] in Blood
44
561
0.78
0.87
3.1
4.8
kpa
7.8
8.1
0.51
44
543
(4094501)
25
346
0.72
0.87
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
131
0.53
0.87
1.0
1.1
—
64.5
—
0
15
(3013290) Carbon dioxide [Partial pressure] in Blood
44
560
0.78
0.87
3.1
4.8
kpa
5.0
5.1
0.08
44
542
(3012501) Base excess in Blood by calculation
44
559
0.78
0.86
3.1
4.8
mmol/l
2.7
2.9
0.20
34
373
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
44
1.82
0.85
1.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
16
239
0.67
0.84
1.1
1.3
u/l
9.8
13.9
0.92
16
218
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
309
0.71
0.84
1.2
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
26
355
0.73
0.84
1.1
1.1
—
681.1
—
0
9
(3037121) Protein [Mass/volume] in Urine
67
808
0.82
0.82
2.2
2.7
g/l
0.3
0.3
0.03
18
288
(42529406) Shigella sp [Presence] in Stool by Culture
66
544
1.22
0.82
1.1
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
23
318
0.72
0.81
1.5
2.0
pg
33.4
32.1
0.64
23
313
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
248
0.68
0.80
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
88
1032
0.85
0.80
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
693
6596
1.07
0.80
2.2
2.4
mg/l
3.0
3.2
1.36
563
5516
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
31
408
0.76
0.80
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
508
0.78
0.79
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
619
6519
0.93
0.79
3.4
3.8
mg/mmol
9.1
10.4
0.29
375
4084
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
24
0.00
0.79
0.0
15.2
—
5.4
—
0
24
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
248
2709
0.91
0.77
2.5
3.2
ng/l
208.7
301.1
4.51
224
2470
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
291
0.72
0.76
1.4
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
28
0.00
0.76
0.0
1.0
—
8.3
—
0
13
(3017732) Neutrophils [#/volume] in Blood
127
1117
1.14
0.75
3.3
3.3
e9/l
4.2
4.3
0.11
83
721
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
193
2133
0.90
0.75
1.9
2.4
umol/l
10.6
10.3
0.05
172
1833
(3024354) Oxygen [Partial pressure] in Venous blood
189
2091
0.90
0.75
2.0
2.9
kpa
4.2
4.3
0.21
181
2003
(3007566) Smooth muscle Ab [Titer] in Serum
26
347
0.75
0.75
1.1
1.1
—
85.5
—
0
20
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
54
1.67
0.74
1.3
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
177
1963
0.89
0.74
2.8
6.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
65
542
1.20
0.74
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
23
167
1.38
0.73
12.0
18.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
33
424
0.78
0.73
1.8
1.9
mmol/l
2.0
1.7
0.53
33
412
(3047189) Immunofixation for 24 hour Urine
6
106
0.57
0.72
1.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
183
0.65
0.72
1.1
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
183
0.65
0.72
1.5
1.9
—
0.6
—
0
7
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
299
0.73
0.72
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
71
599
1.19
0.72
1.1
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
40
1.75
0.71
1.9
1.5
ug/l
11.5
10.0
—
7
40
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
118
1336
0.88
0.70
2.2
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
62
518
1.20
0.70
1.8
2.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
144
0.62
0.69
3.0
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
93
1.51
0.69
1.9
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
93
1.51
0.69
1.9
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
373
3979
0.93
0.69
1.5
1.6
mg/l
1.6
1.6
0.09
281
3127
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
57
683
0.83
0.69
1.5
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
7
120
0.58
0.67
1.1
1.2
u/l
102.0
101.4
—
7
101
(44806118)
13
191
0.68
0.66
1.0
1.3
—
—
—
0
0
(44790047)
13
191
0.68
0.66
1.0
1.3
—
—
—
0
0
(44790048)
13
191
0.68
0.66
1.0
1.3
—
—
—
0
0
(44790049)
13
191
0.68
0.66
1.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
155
0.64
0.65
1.3
1.4
%
9.1
10.2
—
10
155
(3018677) aPTT in Platelet poor plasma by Coagulation assay
379
3560
1.08
0.65
1.6
1.8
s
29.3
30.4
3.08
368
3414
(3014007) Fractional oxyhemoglobin in Arterial blood
160
1445
1.11
0.65
3.6
7.0
%
92.6
93.7
1.20
160
1436
(3017446) Testosterone [Moles/volume] in Serum or Plasma
75
871
0.86
0.64
2.3
2.0
nmol/l
10.7
10.2
0.19
65
717
(3024263) Appearance of Synovial fluid
17
120
1.42
0.64
1.2
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
143
1589
0.89
0.64
2.0
3.0
g/l
130.8
124.6
3.17
138
1552
(3052851) Hemolysis interference index of Serum or Plasma
61
720
0.84
0.64
3.6
3.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
131
0.61
0.63
1.4
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
30
380
0.79
0.62
3.2
3.9
%
2.9
1.6
0.34
21
277
(3022313) Gas panel - Capillary blood
123
1098
1.13
0.62
2.8
3.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
63
1.59
0.61
1.1
1.3
%
—
49.7
—
0
9
(3003694) ABO and Rh group [Type] in Blood
373
3959
0.93
0.61
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
256
0.74
0.61
1.0
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1025
10554
0.95
0.59
4.6
7.7
e9/l
4.7
4.5
0.78
877
9036
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
243
0.74
0.59
2.9
3.5
%
71.5
58.4
—
8
149
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
112
0.62
0.58
1.4
1.8
pmol/l
152.3
206.8
—
7
103
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
63
539
1.17
0.58
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
63
539
1.17
0.58
1.5
1.7
s
19.7
21.9
3.83
54
494
(3001893) Eosinophils/100 leukocytes in Pleural fluid
7
114
0.61
0.58
1.3
1.5
%
0.3
2.9
—
7
90
(3026389) Candida sp identified in Specimen by Organism specific culture
18
242
0.74
0.58
1.6
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
115
0.61
0.57
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
486
5101
0.94
0.57
2.1
2.8
u/l
32.9
36.0
0.78
450
4770
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
207
0.72
0.56
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
184
0.71
0.56
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
65
559
1.17
0.56
3.0
3.8
mg/l
25.9
30.4
0.69
51
389
(3019060) Gas panel - Arterial blood
191
1760
1.09
0.55
2.9
3.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
101
1131
0.89
0.54
1.5
1.8
ug/l
2.9
2.7
0.06
73
943
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
163
1778
0.91
0.54
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
182
0.71
0.54
1.2
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
861
8882
0.95
0.53
3.6
4.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
31
380
0.81
0.51
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
76
862
0.88
0.51
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
145
0.69
0.50
1.3
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
235
0.76
0.49
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
572
0.85
0.49
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
111
0.63
0.48
1.1
1.2
u/l
38.4
27.1
—
7
91
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
76
1.45
0.48
1.7
1.4
umol/l
135.3
104.1
—
6
51
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
256
0.78
0.48
2.0
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
494
4738
1.05
0.47
4.1
4.5
ng/l
199.6
266.0
0.37
420
4279
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
27
332
0.81
0.47
1.3
2.3
%
223.0
217.5
0.11
22
313
(3002619) Bacteria identified in Specimen by Culture
7
48
1.46
0.46
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
321
0.81
0.46
1.5
1.5
iu/l
2.3
4.4
—
9
88
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
142
0.70
0.46
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
118
0.68
0.45
2.4
3.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
84
0.59
0.45
2.0
1.9
—
42.8
—
0
12
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(4268621)
5
85
0.59
0.45
1.6
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
164
0.73
0.45
1.0
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
277
2928
0.94
0.44
1.2
1.2
u/ml
1.3
1.7
0.34
80
685
(3028626) Oxygen [Partial pressure] in Capillary blood
68
602
1.13
0.43
1.9
2.9
kpa
7.6
7.6
0.15
60
555
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
202
1890
1.07
0.43
1.6
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
339
0.82
0.43
1.2
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
14
185
0.76
0.43
1.1
1.1
u/l
70.5
53.6
—
8
124
(40768797) Stomach Pathology biopsy report
227
2413
0.94
0.43
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
240
0.79
0.42
1.2
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
95
0.63
0.42
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
16
0.00
0.41
0.0
5.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
161
0.74
0.41
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
56
492
1.14
0.40
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
229
2426
0.94
0.40
4.1
4.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
504
4861
1.05
0.39
4.0
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
171
0.76
0.39
1.1
1.1
u/ml
345.7
341.1
—
7
90
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
39
453
0.86
0.39
2.3
2.9
u/ml
72.0
1292.2
1.27
34
413
(3032057) Clostridioides difficile [Presence] in Stool
10
71
1.41
0.39
1.9
1.5
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
19
0.00
0.39
0.0
1.2
—
4278.1
—
0
12
(3004616) Nuclear Ab [Presence] in Serum
15
191
0.78
0.36
1.0
1.2
—
—
—
0
0
(44813793)
9
71
1.27
0.36
1.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
245
0.81
0.36
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
342
0.85
0.35
1.2
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
266
0.83
0.35
2.7
2.2
u/field
6.9
2.5
1.45
16
75
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
6
44
1.36
0.34
1.2
1.3
%
—
28.0
—
0
8
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(4146454)
29
246
1.18
0.34
2.0
2.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
186
1969
0.94
0.33
2.6
3.4
mmol/l
1.2
1.2
1.67
149
1675
(3004451) EKG impression Narrative
10
133
0.75
0.33
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
118
1.27
0.33
1.7
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
99
914
1.09
0.32
3.2
4.0
mmol/l
25.1
24.9
0.20
78
803
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
231
0.82
0.32
1.9
1.4
mg/l
1.1
3.1
2.45
14
185
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
52
1.35
0.31
1.0
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
51
456
1.12
0.31
1.3
1.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
7
97
0.72
0.30
1.1
1.3
mmol/l
3.9
3.4
—
7
87
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
99
0.71
0.30
1.1
1.4
%
7.6
18.6
—
7
85
(3000330) Specific gravity of Urine by Test strip
128
1366
0.93
0.30
3.1
4.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
19
229
0.83
0.30
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
22
261
0.84
0.30
1.3
1.8
ug/l
20.7
19.1
0.10
22
255
(3009508) Creatinine [Moles/volume] in Urine
594
6097
0.97
0.30
2.8
3.0
mmol/l
7.2
6.5
3.68
457
4889
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
56
619
0.90
0.29
1.3
1.6
u/l
34.1
37.6
0.61
44
503
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
56
1.25
0.29
1.0
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
268
2570
1.05
0.29
3.2
5.7
%
94.6
95.1
0.44
254
2449
(3044927) Protein electrophoresis panel - Urine
27
313
0.86
0.29
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
184
0.81
0.28
1.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1321
13386
0.97
0.28
20.0
24.4
%
14.0
14.2
5.34
1280
12961
(40760892) CBC W Ordered Manual Differential panel - Blood
320
3319
0.96
0.28
3.0
4.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
512
0.90
0.28
1.3
1.6
e6/l
14401.8
20079.4
0.74
37
363
(3052592) Norovirus Ag [Presence] in Stool
8
65
1.23
0.27
1.1
1.3
—
—
—
0
0
(3010421) pH of Blood
59
646
0.91
0.27
2.8
4.5
ph
7.4
7.4
0.50
44
542
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
37
416
0.89
0.26
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
48
531
0.90
0.26
1.4
1.3
mmol/l
67.5
60.0
0.70
37
421
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
74
801
0.92
0.26
2.4
2.8
pmol/l
4.5
4.2
1.97
64
665
(4306422)
13
104
1.25
0.26
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
73
0.68
0.26
1.0
1.1
nmol/l
141.4
131.9
—
5
73
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
226
2355
0.96
0.25
1.4
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
159
0.82
0.24
1.3
1.7
nmol/l
61.5
50.9
0.48
13
147
(3000570) Elastase.pancreatic [Mass/mass] in Stool
62
570
1.09
0.24
1.4
1.5
ug/g
281.2
258.9
0.46
35
349
(3000012) Reticulocyte production index
13
158
0.82
0.23
1.2
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
38
1.32
0.23
3.0
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
39
1.28
0.23
2.6
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
72
670
1.08
0.22
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
72
670
1.08
0.22
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
644
6567
0.97
0.22
2.1
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
11
0.00
0.21
0.0
1.3
—
0.5
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
10
0.00
0.21
0.0
2.0
—
1.5
—
0
10
(3020618) Glucose [Moles/volume] in Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
4.1
—
0
5
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
2.8
—
0
6
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
157
1640
0.95
0.21
5.1
4.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
239
1.13
0.21
1.6
1.3
mosm/kgh2o
267.9
273.7
0.53
17
158
(3016330) Potassium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
4.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
164
1.16
0.20
1.1
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.9
—
99.0
—
0
14
(3012898) Urea [Moles/volume] in Urine
0
14
0.00
0.20
0.0
1.0
—
103.9
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
108
1.20
0.20
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
176
0.85
0.20
1.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
50
1.20
0.19
1.3
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
118
1.19
0.19
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
53
1.13
0.18
1.8
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
93
981
0.95
0.18
1.3
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
280
2880
0.97
0.18
3.2
5.5
kpa
11.1
11.5
0.66
261
2695
(3003129) Base excess in Capillary blood by calculation
7
59
1.19
0.18
1.3
2.0
mmol/l
1.5
1.3
—
7
54
(36304419) Bacteria [Presence] in Urine
611
6008
1.02
0.17
3.5
3.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
134
1396
0.96
0.17
2.1
3.3
mmol/l
25.0
25.1
0.04
129
1350
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
163
0.86
0.17
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
375
3668
1.03
0.17
3.3
3.3
e6/l
2.6
2.4
0.20
234
2114
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
621
6307
0.98
0.16
3.5
3.6
e6/l
0.6
0.6
0.01
485
4931
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
399
3910
1.02
0.16
2.9
3.4
ug/l
0.9
0.9
0.19
315
2872
(3026782) Osmolality of Urine
480
4886
0.98
0.16
3.1
3.0
mosm/kgh2o
558.9
542.7
1.11
403
4144
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
172
0.87
0.15
1.2
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
281
2879
0.97
0.15
3.2
5.5
kpa
5.0
5.0
0.01
264
2697
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
23
255
0.90
0.15
2.0
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
468
4602
1.02
0.14
4.4
6.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
32
347
0.92
0.14
1.3
1.9
%
60.2
58.4
0.16
32
347
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
118
0.85
0.14
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
103
1.17
0.13
1.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
149
0.87
0.13
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
41
383
1.07
0.13
1.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
117
0.85
0.13
1.3
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
380
3864
0.98
0.12
3.0
3.1
e6/l
1.5
1.4
0.14
233
2283
(3001122) Ferritin [Mass/volume] in Serum or Plasma
780
7879
0.99
0.12
2.4
2.9
ug/l
131.8
150.9
2.00
678
6961
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
137
0.88
0.12
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
115
0.87
0.10
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
177
0.90
0.10
1.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
177
0.90
0.10
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
177
0.90
0.10
1.1
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
135
1.11
0.09
1.4
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.4
2.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
126
1.11
0.09
1.5
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
126
1.11
0.09
1.5
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
58
1.03
0.08
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
58
1.03
0.08
1.2
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
58
1.03
0.08
1.2
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
64
0.78
0.08
1.2
1.7
nmol/l
1.8
7.7
—
5
49
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
195
0.92
0.08
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
39
409
0.95
0.08
1.9
2.1
umol/l
26.6
31.8
0.79
27
321
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
126
1232
1.02
0.07
1.8
2.4
%
1.1
1.1
0.35
126
1226
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
72
0.83
0.07
2.0
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
284
1.06
0.07
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
163
0.92
0.07
1.7
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.0
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.0
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1069
10638
1.01
0.07
3.4
5.5
umol/l
13.4
12.7
0.59
984
9971
(3002173) Hemoglobin [Mass/volume] in Arterial blood
232
2288
1.02
0.06
3.4
6.1
g/l
121.9
118.2
1.91
227
2198
(3048689) Calprotectin [Mass/mass] in Stool
150
1474
1.02
0.06
1.4
1.8
ug/g
182.3
169.9
0.14
109
1111
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
123
1206
1.02
0.06
1.7
2.4
%
0.7
0.7
0.88
117
1155
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
105
0.86
0.06
1.3
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
292
2892
1.01
0.05
3.1
5.5
mmol/l
1.4
1.3
0.11
213
2177
(3032080) INR in Blood by Coagulation assay
991
9871
1.01
0.05
10.6
12.6
inr
1.4
1.4
1.08
254
2599
(3036481) Cortisol [Moles/volume] in Serum or Plasma
153
1551
0.99
0.04
2.0
1.9
nmol/l
411.8
396.3
0.47
125
1371
(3021387) Prolactin [Units/volume] in Serum or Plasma
14
131
1.07
0.03
3.2
1.6
mu/l
308.0
289.1
0.12
14
120
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
151
1.06
0.03
1.6
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
57
558
1.02
0.03
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
118
0.93
0.02
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
16
152
1.05
0.02
1.4
3.0
mmol/l
7.5
7.2
—
9
98
(1002224) Polysomnography panel
20
193
1.04
0.01
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
263
1.03
0.01
2.9
4.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
114
1.05
0.00
1.1
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
114
1.05
0.00
1.1
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
114
1.05
0.00
1.1
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
114
1.05
0.00
1.1
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
156
0.96
0.00
1.9
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
354
1.02
0.00
2.2
2.3
mg/l
38.3
25.8
0.56
15
78
(3015171) Extractable nuclear Ab [Units/volume] in Serum
47
464
1.01
0.00
1.3
1.2
u/ml
0.2
0.7
—
10
38
(3014576) Chloride [Moles/volume] in Serum or Plasma
302
3014
1.00
0.00
3.6
5.5
mmol/l
104.4
104.1
0.38
287
2921
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
165
1.03
0.00
1.5
1.2
—
—
—
0
0
(4062490)
10
99
1.01
0.00
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
265
0.98
0.00
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
191
0.99
0.00
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
269
1.00
0.00
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
271
1.00
0.00
1.1
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
194
1945
1.00
0.00
2.7
3.3
ng/l
85.3
99.3
1.17
153
1574
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
194
0.98
0.00
1.4
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
198
1.01
0.00
1.2
1.2
e6/l
9272.0
225670.6
2.54
14
137
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
272
0.99
0.00
1.1
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
19
187
1.02
0.00
1.1
1.1
mmol/l
40.8
35.2
0.50
12
152
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
78.0
—
0
8
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
89
1.01
0.00
1.1
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
327.0
—
0
8
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
53
0.94
0.00
1.0
1.1
—
81.9
—
0
15
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
74
0.95
0.00
1.1
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
67
0.90
0.00
1.3
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
78
0.90
0.00
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
248.8
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
79
0.89
0.00
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
72
0.97
0.00
7.0
5.7
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
270
1.00
0.00
1.1
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.3
—
20.8
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.9
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
5
56
0.89
0.00
4.8
5.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
270
1.00
0.00
1.1
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
0.7
—
0
6
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
90
1.00
0.00
1.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ADMED_ACHEI_GALANTAMINE – Use of galantamine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).